Stock Market - Trump Administration Seeks to Delist U.S.-Listed Chinese Companies for Blocking Audit Inspections |
- Trump Administration Seeks to Delist U.S.-Listed Chinese Companies for Blocking Audit Inspections
- Deep dive into the technological aspect of Intel's problems
- The Fed bought more blue-chip and junk bonds, and has started making Main Street loans
- Options or stocks for new trader?
- Draftkings
- XERS - Potentially a 15X-20X+ Play for August
- Are there any good books or resources that talk about investing in Biotech?
- Premarket news
- Advice on trading with little money as a college student
- Position Trading vs Investing
- Alert: ONTO
- How many different stocks should you have at a time and why?
- Ally Invest vs Robinhood
- What is everyone's opinion on real estate ETFs like the Vanguard VNQ fund?
- TOS or Webull - what are your experiences?
- HERO ETF
- Robinhood to WeBull transfer question.
- Wayfair vs Overstock
- Do I need a specific style of account to day trade with E*TRADE?
- Watchlist: 8/10 The $1 Trillion Bribe
- Top 4 Things To Know In The Stock Market This Week
- RobinTrack is dead.
- Dear Canadian stock traders, which platform do you use? Is there even a good one?
| Trump Administration Seeks to Delist U.S.-Listed Chinese Companies for Blocking Audit Inspections Posted: 10 Aug 2020 04:53 PM PDT The Donald Trump administration issued a set of recommendations intended to address the long-running inability of the U.S. audit regulator—the PCAOB—to inspect accounting firms based in China whose audit clients are listed in U.S. stock markets. One plan would toughen listing standards on U.S. stock exchanges for what the administration calls non-cooperating jurisdictions (NCJs). But this really targets China as other countries have agreements with the PCAOB. For Chinese companies—such as tech giants Alibaba Group Holding Ltd. and Baidu, Inc.—that want to continue with their listing or want to initiate listing on a U.S. exchange, the PCAOB must have access to audit work papers of the principal audit firm. Companies that cannot grant access because of government restrictions can satisfy this standard by providing a co-audit from an accounting firm "with comparable resources and experience" that the PCAOB determined can conduct proper exams. The new listing standard gives a transition period until January 1, 2022, for already listed companies. The new standards will be immediately applied to new listings after rulemakings become effective. Details of the recommendations are in a July 24, 2020, report drafted by the President's Working Group (PWG) on Financial Markets. PWG is chaired by Treasury Secretary Mnuchin, and he made the report public on August 6. This responds to a June 4 memorandum by President Trump directing the PWG to come up with plans to address the problem. [link] [comments]  |
| Deep dive into the technological aspect of Intel's problems Posted: 10 Aug 2020 05:26 AM PDT Since its' Q2 earnings call a few weeks ago, Intel Corporation (INTC) shares have plummeted 20% upon announcement of problems with its' next-generation 10nm and 7nm manufacturing processes. The massive collapse has led to widespread attention among investors, but in reality the situation has been years in the making for those who've been paying attention. Today I'd like to look at some of the technical decisions Intel made, why they've caused problems and the implications of that on their future. Lithography techniques Lithography is an incredibly complicated process that forms an incredible competitive advantage for those who master it. In simple terms, you put a template of circuit designs (photomask) on a silicon base (wafer) and shine a powerful laser on it [1]. Over time, people tried to fit more transistors in the same area – this would lead to increased performance capability, lower power consumption and various other benefits outlined in Dennard Scaling[2]. This becomes progressively more difficult over time, as you're trying to cram transistors into areas thousands of times smaller than the width of a hair. The industry ran into a particularly tricky wall around the 20nm mark, since the size of the laser you used to 'print' the circuit design became so relatively big that it couldn't reliably follow the complicated patterns needed for all the transistors. Two schools of thought developed to address this problem – patterning (using more than one photomask, each with simpler diagrams, and lasering the wafer with each of these templates separately), and EUV (extreme ultra-violet, using radiation with much smaller wavelengths than traditional). Intel saw success with dual-patterning (two templates) on its' 22 and 14nm process, and chose to go one step further and pursue quad-patterning on its' 10nm process.[3] Meanwhile, its' competitors TSMC and Samsung chose EUV. [4] For reference, Intel themselves have also chosen to pursue EUV for their 7nm process. That might give you a hint as to which was the right choice… Other terminology I'll be referring to in this piece are yield (how much of a wafer is actually useable) and monolithic (the whole CPU is cut out of the wafer as a single piece of silicon) vs chiplets (the CPU is formed from several pieces of silicon stuck together) The problems with 10nm Back in 2013, Intel was in it's prime. It dominated the CPU market with >90% market share, and was pursuing a tick-tock strategy with its' chips – every two years you would have a die shrink 'tick', then the alternating years you would have a microarchitecture change 'tock'. In the roadmaps released by Intel, they planned to have their next 'tock' of 10nm in 2016. The 'tick' – Skylake architecture came, but the 'tock' never did. Even today, 4 years after it was supposed to be released, 10nm still isn't really here. On paper, it was launched with Cannon Lake in 2018 – but the total number of those are in the thousands, if not hundreds. On paper, the 'mass-market' generation Ice Lake launched in 2020 but they have incredibly limited supply and offer inferior performance to Intel's own 14nm offerings. [5] The latest update is that desktop and datacentre chips will come in the second half of 2021 – but for reasons we shall soon see it is my opinion that these will yet again be flops. In fact, it is my opinion that 10nm is a total writeoff, and that the design decisions taken at a very early stage have doomed it to failure. When you use lithographic techniques, you are bound to have some defects in your wafer. After all, creating billions of devices tens of atoms in size isn't going to be perfect. Patterning as a lithographic technique inherently has a higher defect rate than not using it – you're basically going through the same process multiple times, thus increasing the chance of defect dramatically. As I mentioned earlier, Intel is using quad patterning in 10nm – this means their defect rates are going to be sky high. At the same time, their usage of a monolithic die compounds this problem for high-performance, high core count CPU models. As you can see from the blue wafer below, it's difficult to draw large squares (high-core count models) that are without defect. In comparison, the red wafer is AMD's chiplet approach, built on TSMC's less defect-prone EUV process. (Sorry, I copied this post from my blog to not self-promote but I can't insert the relevant pictures here) Since you can paste together multiple small CPUs into one bigger one, you use a far greater percentage of the wafer, cutting costs and letting you freely choose however many high-performance chips you want to build. Of course, it's impossible for anyone outside Intel to know the exact numbers for the defect rates, yields and unit costs for 10nm. No doubt they are improving as time goes on,as they always do with a maturing architecture. However, I can say with certainty that
These are bold statements but I believe Intel's actions over the past few years, and their planned actions over the next few, support this view. When you release a new generation of processors, you always want to have it be 'better' than the previous generation. This may seem incredibly obvious, but the only exception is when the design has such big inherent flaws that you can't physically do so. For instance, the Bulldozer architecture AMD released in 2011 performed worse than their own previous-generation Phenom II architecture [6], leading to near-bankruptcy of the company, due to the flawed design of maximising core counts from a belief that multi-threaded performance was the future; while having the processor cores shares caches and FPUs, massively reducing the multi-threaded performance of the architecture. Intel finds themselves in a similar situation today. Their design choices made back in 2013 mean that it is impossible to mass produce 10nm high core count chips. This would've been fine if their monopoly continued and the mainstream continued to have 4 core, 8 threaded CPUs. Indeed, they are producing Ice Lake laptop CPUs today that have 4 cores. However, the resurgence of AMD with their high core count capable Zen architecture meant that Intel were forced into raising their own core counts to compete – there has been a doubling of core counts across their entire product stack, which is fine on 14nm with its' double patterning, but not so much on 10nm. The limitations of 10nm mean that current generation chips at the same price point from Intel have 14nm massively outperforming 10nm, with the higher core counts outweighing any density improvements that 10nm brings. Similarly, leaks for the upcoming 10nm Alder Lake desktop and Ice Lake Xeon chips suggest that the maximum number of cores on 10nm,28, will be 33-50% lower than those from 14nm [7] – not to mention AMD's offerings which top out at 2.3x the core count at half the price.[8] The persistent lack of chips on 10nm that can outperform their predecessors, despite us now technically being on '10nm+++', suggests that there is a fundamental barrier in the technology that no amount of delays and extra engineering can get past. 10nm is rotten from the very first steps taken. 7nm and beyond So now we've established just how much of a disaster Intel's 10nm process is, what about 7nm? It should be better right? After all, its' built on the superior EUV, rather than SAQP. The market obviously expects it to be Intel's saviour, given the massive drop in Intel share price was widely attributed to the '6 month delay' in 7nm rollout. While I don't have nearly as much solid information to go on compared to 10nm, I just want to note a few things. The exact words Bob Swan used in the Q2 call were 'we are seeing a 6 month shift in 7nm… 12 months behind our internal target… we have identified a defect mode that resulted in yield degradation'. There's quite a lot to break down here. Many people, including analysts on the call, were confused by how 7nm could be both 6 and 12 months behind target at the same time. Have Intel achieved quantum tunnelling of time? The truth is that Bob's claim of a 'buffer in planning process' as the reason, while technically true, is incredibly misleading. In any typical launch of a new process node, you spend a few months getting up to speed – running the foundry through the whole process, troubleshooting, using the produced chips as prototypes to send to OEM partners for them to design products around, etc. You don't sell the chips produced to anyone. Industry standard is to call this period a tape-out, not a launch of a new process – that's when you actually produce chips that you sell to people. Bob's comment translated is that the process is delayed by 12 months, but they're going to breach industry standard and 'launch' 7nm when the first fabs start spinning up 6 months before they have chips in any volume. Sound ridiculous? Well, Intel did the exact same thing with 10nm. Faced with mounting pressure over the constant delays, Intel 'launched' Cannon Lake in May 2018. There was 1 CPU in the whole generation, a dual core processor with a clock speed of 2.2Ghz that was slower than the i3-3250 released in 2013 for $20 less than the 10nm part. Not to mention it was nigh on impossible to actually buy one.[9] Cannon Lake was an incredibly obvious paper launch, released to appease investors at a time where Intel had just started up its fabs. Ice Lake, the first 10nm architecture you could actually buy (in limited quantities) shipped in September 2019, more than a year after Cannon Lake 'launched'. This '6-month' delay is nothing more than an attempt to sweetcoat a 12 month delay (assuming no further delays). The second part of the comment, relating to a 'defect mode', is just as interesting as the first. Intel are attempting to use GaaFeT technology for their 7nm process, though there's conflicting information suggesting they might move away from this if it proves to be too difficult. [10] GaaFet, or Gates-all-around-Field-effect-Transistor, is a new and unproven transistor technology that should overcome the technical difficulties current transistor technologies face at increasingly smaller sizes. Unlike normal process shrinks, this is going to a completely new type of transistor and we only have one other comparable in history – the transistor to a 3D FinFeT technology a few years ago. With FinFet, the research process from having a 'working prototype' demonstrating commercialisation potential took 8 years. [11] Meanwhile, the equivalent demonstration with GaaFeT took place 3 years ago. [12] While FinFeT and GaaFeT are different beasts, it is undeniable that the plans from Intel, and indeed all other foundries, are incredibly ambitious. The latest leaks suggest that the 'defect mode' Intel have ran into has to do with their GaaFeT implementation. If this is true, you could easily see 7nm being just as much of a disaster as 10nm is. Beyond 7nm, there are some positives to be found. As we get even smaller transistors, it will be necessary for both EUV and patterning to occur. It's likely that Intel will have an advantage in this area compared to competitors due to their experience with 10nm. At the same time, they are actively exploring chipletbased designs. They might have been late in realising the benefits, but they've finally come around with their EMIB, Foveros and big.Little technologies, all of which I'll explore in a future blog post. Conclusion I'll leave it to you to decide what the financial implications of these deductions are for Intel, but suffice it to say the baseline scenario is far worse than what many people envision. There is no doubt that Intel will recover from this fiasco, but at what cost? Will it require yet another management reshuffle? Following in the footsteps of AMD, outsourcing production fully and writing off its' own fabs? Acknowledgement that they will no longer be able to extract incredible margins from their monopolistic position? References [1] http://www.lithoguru.com/scientist/lithobasics.html [3]2019 Intel Investor Meeting Presentation, slide 9 [5]https://www.anandtech.com/show/15385/intels-confusing-messaging-is-comet-lake-better-than-ice-lake [6]https://www.techspot.com/review/452-amd-bulldozer-fx-cpus/page13.html [7]https://wccftech.com/intel-10nm-ice-lake-sp-xeon-cpu-28-core-56-thread-cpu-benchmarks-leak/ [8]https://www.amd.com/en/products/cpu/amd-epyc-7742 [9]https://www.anandtech.com/show/13405/intel-10nm-cannon-lake-and-core-i3-8121u-deep-dive-review [10]https://twitter.com/chiakokhua/status/1288402693770231809 [link] [comments]  |
| The Fed bought more blue-chip and junk bonds, and has started making Main Street loans Posted: 10 Aug 2020 12:13 PM PDT The Federal Reserve continued its purchases of corporate bonds in July, buying up both blue-chip and junk issues. In addition, the central bank made its first move through the Main Street Lending Program, though the loans totaled just $92 million for a program that can lend $600 billion. [link] [comments]  |
| Options or stocks for new trader? Posted: 10 Aug 2020 03:12 PM PDT I'm looking to get into the stock market. Are options or stocks the way to go? I don't really mind the risk of options, and would rather risk it for bigger returns. [link] [comments]  |
| Posted: 10 Aug 2020 01:22 PM PDT I currently own a small amount of DKNG. With the return of sports I expected the stock to increase, but it has continued to sink continuously lower. Was curious if others have reason to believe the stock will rise again, or continue to worsen. Thanks [link] [comments]  |
| XERS - Potentially a 15X-20X+ Play for August Posted: 10 Aug 2020 05:04 AM PDT Someone has recently pointed out this company to me. I did a lot of research and now believe it's the best trading opportunity for Aug 2020. I've compiled my own and other investors' research – read below. Overview Xeris Pharmaceuticals (XERS, see https://www.xerispharma.com) looks completely overlooked and undervalued. They've recently created a breakthrough product (Gvoke HypoPen) that is now believed to be the best emergency treatment for severe hypoglycemia (low blood sugar – see https://www.healthline.com/health/hypoglycemia). The Gvoke HypoPen (see https://www.gvokeglucagon.com) is similar to an EpiPen (it treats hypoglycemia in an emergency situation). There is a huge market for this due to the growing number of people diagnosed with diabetes. According to an older CBS article "371 million people had diabetes globally in 2012… By 2030, they expect 552 million people will have the disease." (see https://www.cbsnews.com/news/371-million-people-have-diabetes-globally-about-half-undiagnosed). It is apparent that hospitals, schools, and regular businesses will be phasing out their Glucagon medical kits for the new Gvokes. Furthermore, there are millions of individual diabetics that will want to have these accessible in case of emergency. Gvoke is currently covered by about 80% of insurance companies in the US with $0 copay. Moreover, Gvoke is close to approval in EU. The company's debt is very reasonable and they have plenty of cash on hand. Xeris actually has trouble producing enough Gvokes to meet all the recent demand. Catalysts There seems to be a perfect storm of factors that could propel the XERS stock and options into the stratosphere: • Recently launched (July 1st) game-changing product (Gvoke HypoPen, see https://finance.yahoo.com/news/xeris-pharmaceuticals-announces-gvoke-hypopen-110000083.html) • Earnings report & conference call - Mon 08/10/20 – Today! Due to new sales of Gvoke HypoPen, the next ER is likely to show solid numbers (see https://finance.yahoo.com/news/xeris-pharmaceuticals-announce-second-quarter-200500496.html) • Active Stock/Low float The stock has been very active and liquid recently with over 2M shares traded daily (with a tight spread of $0.01 most of the time). XERS has a pretty low float of about 27M shares with 58% held long-term by institutions. • Reduced stock price (about $3.30 and rising at the time of writing) The XERS price has recently dropped due to overreaction to a public offering. It presents a great opportunity to purchase at the right price • Short squeeze Recently increased short borrow rate across various brokers (see https://twitter.com/dteb16/status/1287783290347368449, as an example) makes shorting XERS much harder. Between that, the upcoming ER + other good news, we are likely to see a major short squeeze in the next few weeks • George Soros – recently disclosed a 5.3% stake (about 2.5M shares) in the company (see https://www.smarteranalyst.com/yahoo/xeris-spikes-12-after-hours-on-soros-stake-analyst-says-buy/amp). It's a great sign when such prominent investors purchase a large block of stock in line with 58% of total institutional ownership • Medium 12-month XERS price target (based on 4 analysts) is $12.50, with a high forecast of $15.00 (see https://www.tipranks.com/stocks/xers/price-target, https://finance.yahoo.com/news/2-beaten-penny-stocks-look-193735305.html). • A $4.1M contract (see https://beta.sam.gov/opp/acb59c12ce004ebf832c456d8c10d283/view) was awarded to Xeris on July 1st by the Department of Veteran Affairs, which is for some reason still unannounced • Many other products at different developmental stages in the company's pipeline (several versions of Glucagon, Diazepam, Pramlintide-Insulin, etc.) – see https://www.xerispharma.com/research-development/pipeline Risk/Reward It seems to me that the reward far outweighs the risk in this case. There's an overwhelming amount of evidence pointing to the significant upside (see Catalysts). Conclusion There is already a major buzz around the stock and the price is starting to reflect it. With everything that's happening, my conservative target for XERS stock is $15-$17 within the next few months (would make options earn a very nice multiple). Everything feels like XERS is getting ready to explode. TLDR: I am currently buying/accumulating XERS stock and options - 09/18/20 $5c, 10/16/20 $5c & 01/15/21 $5c. This looks like a great ground-floor opportunity to me. If you agree – join me before all other investors pile in and price explodes. These are my own opinions, I'm not a financial advisor. This post is not investment advice. [link] [comments]  |
| Are there any good books or resources that talk about investing in Biotech? Posted: 10 Aug 2020 03:54 PM PDT I've been losing consistently on Biotech's because they are constantly rocketing and being dumped. FDA Releases and Outlook Data are constantly factored in and you never know how traders and Algos will take the information. [link] [comments]  |
| Posted: 10 Aug 2020 07:55 PM PDT Hey all wanted to get an suggestions on morning radio shows or YouTube live channels for morning news on upcoming day on the market. I do as much reading in the morning but don't have time to do a lot. I spend a lot of time cooking breakfast, laundry, taking dogs out and need something to listen to pre market. If you have any suggestions it be greatly appropriated [link] [comments]  |
| Advice on trading with little money as a college student Posted: 10 Aug 2020 05:00 AM PDT Hello everyone, Hope ya'll are well! I'm a 20y.o. college student studying Accounting and Finance. I have $700 (currency in USD) to burn and would really like to use this money to kick start trading. I'm from Australia and will be using Stake to trade in the US markets. I've been eyeing high dividend ETFs such as $SPHD, $SCHD and $SPYD as well as growth ETFs such as $VUG and $MGK. Being a young man like myself, I have a high risk tolerance and would like to start passive investing in ETF funds with a long term outlook (8years); with hopes of taking what I sow to use as a down payment for my first house. I'm currently out of work due to the pandemic and would probably stay jobless till July next year. Once I get back on my feet, I'll put approx. $25 each week into trading. Would like to hear some ETF suggestions for my situation now (elaborations are appreciated). Should I dollar cost average in my case? Also, which is more worthwhile; buying many cheap stocks OR buying a few expensive stocks. Thank you all. [link] [comments]  |
| Posted: 10 Aug 2020 07:12 PM PDT I was reading about the different types of trading which are day trading, swing trading and position trading. However the line between position trading and investing seems a bit blurred. If my average holding time is 1 to 1.5 years, am I considered a position trader or an investor? [link] [comments]  |
| Posted: 10 Aug 2020 11:38 AM PDT ONTO > AMAT, here's why. ONTO has a technological edge with their equipment and are way under valued. They are taking at about 21 P/E right now, but as they build out their portfolio, they expect to earn over $5/sh with increased margins. So, a FPE of closer to 7. AMAT is a great company, but they are already built out. ONTO has that TAM SAM gap to fill in addition to eating market share and the growing industry. I wouldn't be shocked if AMAT or LRCX buys ONTO, frankly. It would make sense. They have Advanced node and advanced packaging. As customers move toward 3nm 6th gen dual layer, they need Atlas III. And with pattern control software with machine learning, they provide an end to end solution. So if Intel or Western Digital want to survive in their competitive marketplaces, they need to have the best tools to print the wafers. They are a small company, but they are #1 or #2 in their core markets. They win because they have the best tools. Thanks u/JakeSmithsPhone for putting this together, just wanted to get more people in the know. [link] [comments]  |
| How many different stocks should you have at a time and why? Posted: 10 Aug 2020 06:51 AM PDT New to trading! Teenager. I'm wondering how many different stocks I should be holding at a time. I think I read a comment here that 40 different companies is too many to monitor. I also know to diversify my portfolio. How much is too much? Is there a number you generally follow as a strategy? [link] [comments]  |
| Posted: 10 Aug 2020 05:58 PM PDT Hey guys. I'm trying to start investing and I'm trying to figure out what platform I should use. I've heard good things about Robinhood, but I've already got access to ally Invest. Which is better? What are some differences? Also I'll take other suggestions [link] [comments]  |
| What is everyone's opinion on real estate ETFs like the Vanguard VNQ fund? Posted: 10 Aug 2020 05:18 PM PDT The real estate market doesn't seem to feel the effects of COVID-19 with most sellers still wanting top dollar for their properties and by all accounts it still a seller's market. However the ETFs like VNQ, IYR and SCHH funds have taken a beating. Also these funds had a strong upward movement before the virus. What are your thoughts? [link] [comments]  |
| TOS or Webull - what are your experiences? Posted: 10 Aug 2020 05:17 PM PDT I'm trying to decide between TOS and Webull for a day trading platform. I like both, but can't come around to choosing only one. Please comment your experiences and recommendations. Thank you! [link] [comments]  |
| Posted: 10 Aug 2020 04:54 PM PDT Hey guys since online gaming Is only getting bigger and more competitive what do you guys think of the new ETF HERO? Esports itself is only getting bigger and paying out more prize money and more and more games are being created for competitions every year. [link] [comments]  |
| Robinhood to WeBull transfer question. Posted: 10 Aug 2020 03:25 PM PDT Sick of getting screwed over by Robinhood's shit PM and AH hours. How do I go about transferring the funds and how much will it cost? I have 190$ in the account currently (would be more but I constantly get screwed by Robinhood and their crap hours.). Also, other than better trade hours are their other benefits to WeBull? [link] [comments]  |
| Posted: 10 Aug 2020 03:25 PM PDT Can someone tell me how Wayfair has a $28B market cap and Overstock is only at $3.8B when they're both very similar furniture e-commerce but Overstock is also diversified in crypto? Is it more likely that Wayfair is way overvalued or Overstock is way undervalued? [link] [comments]  |
| Do I need a specific style of account to day trade with E*TRADE? Posted: 10 Aug 2020 02:21 PM PDT I am curious and also new to a lot of this. I want to put some money into RKT and make a quick buck but it says the AAL stock that I sold last week still hasn't settled into my account and if I were to buy and sell the new stock before it settles I could get a 90 day gold on my account. What am I missing? [link] [comments]  |
| Watchlist: 8/10 The $1 Trillion Bribe Posted: 10 Aug 2020 04:29 AM PDT Market Notes: Friday was a choppy day but the markets ended the day and the week higher. Safe havens from gold to bitcoin are continuing to surge higher as the dollar is showing some weakness. In Washington, President Trump signed executive orders to extend unemployment benefits and start a payroll tax holiday. According to the constitution, the President does not have the power to do this. The President, in an apparent bribe to voters, promised to make the tax cuts forgivable if he was reelected. Congress has given up some constitutional powers in recent decades without any real fight. I doubt they will give up the powers of the purse. The unemployment benefits require the states to pick up part of the bill. Cash the states just don't have. I think stocks, gold, and bitcoin are going to continue climbing as investors more assets out of the US Dollar. Watchlist: CSLK is a low float, watching for setup above $9.60 SMED is a low float, resistance at $9 IMMR is a low float, resistance at $8.23 BGFV is a low float, support at $7 LITB is a lowish float, support at $2.42 SIGA has resistance at $8 ATEC has resistance at $7 ZSAN has resistance at $1.60 CBAY has support at $6 MBII has support at $1.30 TRVN has support at $3.50 PACB has support at $4.60, resistance at $4.80 PBI watching for a setup above $6.39 RRC watching for a setup above $8.25 PLUG watching for a setup above $11.75 [link] [comments]  |
| Top 4 Things To Know In The Stock Market This Week Posted: 10 Aug 2020 06:01 AM PDT U.S. Stock Futures Mixed After Trump Orders Coronavirus ReliefU.S. stock futures were mixed early Monday morning after President Donald Trump signed several executive orders aimed at extending coronavirus relief. Dow Jones Industrial Average and the S&P 500 futures were up 0.33% and 0.15% respectively as of 3.46 a.m. ET on Monday, while Nasdaq 100 futures were 0.05% lower. U.S. And China Still At OddsThe U.S.-China tensions have been going from bad to worse and there's no other way to put it. It appears to be heading to a point of no return. As if slapping tariffs at each other and cancelling trades are not bad enough. Just this year, the US regulators made it difficult for Chinese companies to list in the US stock exchanges and faces potential delisting of Chinese companies if they do not comply with the requirements. And most recently, the ban on famous Chinese apps namely TikTok and WeChat is straining the relationship further. If there's no consensus between the U.S. and China in the TikTok deals, certain tech stocks, both large and small cap in both countries are expecting to take a hit. Corporate Earnings Continue To Wind DownEarnings season continues this week with another set of companies reporting quarterly earnings results, including a few newly listed companies set to announce their quarterly reports for the first time. Among those closely watched will be Lyft (LYFT Stock Report), NetEase (NTES Stock Report), Canopy Growth (CGC Stock Report). The fresh faces making their first public announcement this week are Lemonade (LMND Stock Report), ZoomInfo Technologies (ZI Stock Report) and Vroom Inc (VRM Stock Report). Some of these companies have seen soaring stock prices. The earnings releases will likely provide a reality check for the enthusiastic investors. The newly listed companies have at least doubled in stock prices. Yet, they have so far not seen much significant news that can affect their stock prices. This came as investors continue to be optimistic about the prospects of these newly public companies. Perhaps they are afraid of missing out on the expected growth. With a lack of company guidance, it remains to be seen how the market will react. After all, the market doesn't necessarily agree with analysts' consensus. Defensive Sectors To Rise, Value Stocks GainIt's certainly an interesting year for financial markets. It's easy not to notice that the S&P 500 Index is now just around 1% below its record high. Recent gainers included defensive sectors such as utilities and real estate. Tech stocks which were the primary driver of the market rally since March appear to be taking the back seat now. Does that mean we are expecting to see a decline in Nasdaq Composite or the rise in "reopening stocks" this week? Fundstrat's Tom Lee agrees with the latter. The reopening stocks, also called "epicenter stocks" by Lee, are stocks that should benefit from a steady reopening of the US economy. These include the travel, leisure, and hospitality sectors. With the research carried out by his team in Fundstrat, they conclude that the epicenter stocks are set to outperform sometime this week. He pointed to Friday's unemployment report, which showed a 50% retracement of jobs lost since the pandemic began. That to him, signals that the economy is healthy and recovering. Of course, he could be wrong too. Ultimately, we need to see how investors react to market sentiments and see if these epicenter stocks could really gain momentum to have another "monstrous rally" before these cyclical stocks could rally big. [link] [comments]  |
| Posted: 10 Aug 2020 09:20 AM PDT Now we can't even check how many people are bagholding HTZ and GNUS; Robinhood are doing me a sad. On a serious note, though, they really don't want the retail trading morons on RH to realize they're Wall Street's bagholders, so I guess they had to pull the data and deprive their users of even more context. Pretty scummy in my book. Fuck RH entirely. [link] [comments]  |
| Dear Canadian stock traders, which platform do you use? Is there even a good one? Posted: 10 Aug 2020 08:36 AM PDT Hi, I'm new to canadian stock trading. Apprantly there exists only 2 platforms Wealth simple and Questrade. Problem with WS is it doesn't have all the stocks, options, has 15 min delay when it comes to US stocks, and currency-conversion charges when you buy US stocks. It's the delay that puts me off, as stock market is all about timing. Questrade is commission based and has lots of different kind of fees involved Hence, my question, is there any other canadian platform where i can do fast, real time trading in both US and Canadian stocks without absurd fees or is it worth going for Questrade with all the fees involved? Thanks. [link] [comments]  |
| You are subscribed to email updates from r/StockMarket - Reddit's front page of the stock market, financial news. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States | |
No comments:
Post a Comment